![]() |
![]() | |||||
|
Zarontin for Seizures
What is a seizure?A seizure is an abnormal and unregulated electrical impulse that happens in the brain’s cortical gray matter. It temporarily interrupts normal brain function. It usually causes altered awareness of circumstances, unusual sensations, focal involuntary movements or spasms -- involuntary contraction of voluntary muscles. About 2% of adults have a seizure at some point during their life while two thirds of that 2% never have a second one. What is Zarontin?Zarontin is an anticonvulsant succinimide used in the control of absence (petit mall) epilepsy, particularly in young children. It has no effect against (or may even worsen) most other types of seizures. It’s generic name is ethosuximide. It’s marketed in the United States by Parke-Davis (a division of Pifzer). The name or appearance may be different in other countries but usually the dose, measured in milligrams, is the same worldwide. How Does Zarontin Work?
Zarontin suppresses the sudden outburst of the three cycle per second spike and wave activity associated with lapses of consciousness. These are common in petit mal or absence seizures. Therefore the frequency of these attacks is reduced. This apparently happens because of the depression of the motor cortex which elevates the threshold of the central nervous system to convulsive triggers or stimuli. Most EEGs become normal while a patient is on Zarontin. What is the History of Zarontin?
In 1989 ethosuximide began to be analyzed as a preventative for absence seizures. In 1998 it was concluded further that ethosuximide (Zarontin) decreased Na+ current, which was responsible for absence seizures. Zarontin capsules were discontinued in 2007 by Pfizer. Syrup preparations are still available.
| |||||
|
| ||||||
|
|
|
| ||||